Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis

The lowest dosage of empagliflozin (10 mg) showed similar benefits on glycated hemoglobin (HbA1c) level, body weight, blood pressure, and total and cardiovascular mortality in comparison with the highest available dose (25 mg) in the EMPAREG trial. These findings have not been clearly demonstrated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Lana C., Rados, Dimitris V., Remonti, Luciana R., Viana, Marina V., Leitão, Cristiane B., Gross, Jorge L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991024/
https://www.ncbi.nlm.nih.gov/pubmed/35263050
http://dx.doi.org/10.20945/2359-3997000000440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991024/
https://www.ncbi.nlm.nih.gov/pubmed/35263050
http://dx.doi.org/10.20945/2359-3997000000440

Ejemplares similares